Focue Provides the Latest and Most Up-to-Date News, What You Focus On is What You Get.
⎯ 《 Focue • Com 》

List of All Articles with Tag 'novo'

Suicide Risk From Weight-Loss Drugs Prompts More EU Questions
Suicide Risk From Weight-Loss Drugs Prompts More EU Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
1970-01-01 08:00
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
By Patrick Wingrove (Reuters) -Novo Nordisk said on Thursday it sued one compounding pharmacy and refiled a lawsuit against another
1970-01-01 08:00
Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Jumps 66% After Positive Results for Its Obesity Drug
Altimmune Inc. jumped as much as 66% in late trading after the biotech company reported results from a
1970-01-01 08:00
Forget Novo, Rolls-Royce Is Europe’s Best Stock This Year
Forget Novo, Rolls-Royce Is Europe’s Best Stock This Year
Rolls-Royce Holdings Plc just extended its status as Europe’s best performing stock this year. The shares rose as
1970-01-01 08:00
Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
Long-Time Novo Bull Slashes Stake Citing Weight-Loss Drug Hype
A top-performing European fund manager is calling time on “hype” around weight-loss drugs that has sent Novo Nordisk
1970-01-01 08:00
Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site
Ozempic Maker Novo Nordisk Invests $2.3 Billion in France Site
Novo Nordisk A/S, which faces supply bottlenecks amid high demand for its blockbuster weight-loss medicines, will invest €2.1
1970-01-01 08:00
Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France
Macron to unveil 2.1 billion eur Novo Nordisk pharma investment in France
PARIS French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro ($2.3 billion) investment by Danish
1970-01-01 08:00
New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype
New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype
A niche issuer is launching a biotechnology exchange-traded fund whose key holdings include firms benefiting from the hype
1970-01-01 08:00
Novo Nordisk Staff Get Free Wegovy As a Perk If They Need It
Novo Nordisk Staff Get Free Wegovy As a Perk If They Need It
If you’re a Novo Nordisk A/S employee with obesity, you will have access to a unique company perk:
1970-01-01 08:00
Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany Mulls Obesity Drug Export Ban as EU Confronts Shortage
Germany is considering an export ban on Novo Nordisk A/S’s blockbuster weight-loss drugs as European countries try to
1970-01-01 08:00
Medical device makers rise on relief after Wegovy obesity trial data
Medical device makers rise on relief after Wegovy obesity trial data
Shares of U.S. medical device makers climbed in early trading on Monday as a potential hit from the
1970-01-01 08:00
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
Novo Nordisk shares rise as Wegovy shows heart benefits beyond weight loss
By Maggie Fick LONDON (Reuters) -Novo Nordisk shares rose 3% on Monday as the market reacted to data the drugmaker
1970-01-01 08:00
«1234»